[HTML][HTML] Pseudomonas Aeruginosa: Resistance to the Max

K Poole - Frontiers in microbiology, 2011 - frontiersin.org
Pseudomonas aeruginosa is intrinsically resistant to a variety of antimicrobials and can
develop resistance during anti-pseudomonal chemotherapy both of which compromise …

[HTML][HTML] Intensive care unit bugs in India: how do they differ from the Western world?

D Chaudhry, B Prajapat - The Journal of Association of Chest …, 2017 - journals.lww.com
Infections continue to play a significant role in the overall global mortality and disability more
so in Intensive Care Units (ICUs) and plague developing countries more intensively. The …

[HTML][HTML] ESBL, MBL and Ampc β lactamases producing superbugs–Havoc in the Intensive Care Units of Punjab India

L Oberoi, N Singh, P Sharma… - Journal of clinical and …, 2013 - ncbi.nlm.nih.gov
Background: An alarming rise in the rates of the antibiotic resistance has now become a
serious and an increasingly common public health concern, with severe implications …

Presence of different beta-lactamase classes among clinical isolates of Pseudomonas aeruginosa expressing AmpC beta-lactamase enzyme

S Upadhyay, MR Sen, A Bhattacharjee - The journal of infection in …, 2010 - jidc.org
Abstract Introduction: Infections caused by Pseudomonas aeruginosa are difficult to treat as
the majority of isolates exhibit varying degrees of beta-lactamase mediated resistance to …

[HTML][HTML] AmpC beta lactamases among Gram negative clinical isolates from a tertiary hospital, South India

PR Mohamudha, BN Harish, SC Parija - Brazilian Journal of …, 2010 - SciELO Brasil
AmpC β-lactamases are cephalosporinases that hydrolyze cephamycins as well as other
extended-spectrum cephalosporins and are poorly inhibited by clavulanic acid. Although …

Prevalence and characterization of beta-lactamase-producing Escherichia coli isolates from a tertiary care hospital in India

A Govindaswamy, V Bajpai, S Khurana… - Journal of laboratory …, 2019 - thieme-connect.com
BACKGROUND: The purpose of the study was to determine the prevalence and
characterize the resistance profiles of Escherichia coli isolated from various clinical …

[HTML][HTML] Molecular description of plasmid-mediated AmpC β-lactamases among nosocomial isolates of Escherichia coli & Klebsiella pneumoniae from six different …

PR Mohamudha, BN Harish… - Indian Journal of Medical …, 2012 - journals.lww.com
Methods: A total of 241 nosocomial isolates of K. pneumoniae (n= 109) and E. coli (n= 132)
from six geographically distant hospitals in India were included. These were screened for …

Pseudomonas aeruginosa: Multi-drug-resistance development and treatment options

G Meletis, M Bagkeri - Infection Control, 2013 - books.google.com
Antibiotic resistance is a worldwide problem of major importance. Isolations in some
countries of multi-drug-resistant (resistant to three or more classes of antimicrobials) …

[HTML][HTML] Occurrence and characterization of genetic determinants of β-lactam-resistance in Escherichia coli clinical isolates

R Tewari, F Ganaie, N Venugopal, S Mitra… - Infection, Genetics and …, 2022 - Elsevier
Abstract β-lactamase mediated resistance in Escherichia coli is a significant problem that
requires immediate attention. Herein, we aim to characterize and understand the dynamics …

[HTML][HTML] AmpC β-lactamases in nosocomial isolates of Klebsiella pneumoniae from India

V Gupta, K Kumarasamy, N Gulati, R Garg… - Indian Journal of …, 2012 - journals.lww.com
Methods: One hundred consecutive, non-duplicate clinical isolates of K. pneumoniae
collected over a period of one year (June 2008-June 2009) were included in the study. An …